AAAAAA

   
Results: 1-25 | 26-50
Results: 1-25/50
OVARIAN TISSUE-BANKING IN PATIENTS WITH HODGKINS-DISEASE - IS IT SAFE
Authors: MEIROW D BENYEHUDA D PRUS D POLIACK A SCHENKER JG RACHMILEWITZ EA LEWIN A
Citation: D. Meirow et al., OVARIAN TISSUE-BANKING IN PATIENTS WITH HODGKINS-DISEASE - IS IT SAFE, Fertility and sterility, 69(6), 1998, pp. 996-998
ENHANCED GENERATION OF MONOCYTE TISSUE FACTOR AND INCREASED PLASMA PROTHROMBIN FRAGMENT(1-VERA - MECHANISM OF ACTIVATION OF BLOOD-COAGULATION(2) LEVELS IN PATIENTS WITH POLYCYTHEMIA)
Authors: KORNBERG A RAHIMILEVENE N YONA R MOR A RACHMILEWITZ EA
Citation: A. Kornberg et al., ENHANCED GENERATION OF MONOCYTE TISSUE FACTOR AND INCREASED PLASMA PROTHROMBIN FRAGMENT(1-VERA - MECHANISM OF ACTIVATION OF BLOOD-COAGULATION(2) LEVELS IN PATIENTS WITH POLYCYTHEMIA), American journal of hematology, 56(1), 1997, pp. 5-11
IMPROVED METHOD FOR DIAGNOSIS OF POLYCYTHEMIA-VERA BASED ON FLOW CYTOMETRIC ANALYSIS OF AUTONOMOUS GROWTH OF ERYTHROID PRECURSORS IN LIQUIDCULTURE
Authors: MANOR D RACHMILEWITZ EA FIBACH E
Citation: D. Manor et al., IMPROVED METHOD FOR DIAGNOSIS OF POLYCYTHEMIA-VERA BASED ON FLOW CYTOMETRIC ANALYSIS OF AUTONOMOUS GROWTH OF ERYTHROID PRECURSORS IN LIQUIDCULTURE, American journal of hematology, 54(1), 1997, pp. 47-52
ANNEXIN-V BINDING TO THALASSEMIC ERYTHROCYTES CORRELATES WITH THE EXPRESSION OF PLATELET P-SELECTIN AND REFLECTS A THROMBOPHILIC STATE
Authors: RUF A PICK M DEUTSCH V GOLDFARB A RACHMILEWITZ EA BEZEAUD A GUILLIN MC PATSCHEKE H ELDOR A
Citation: A. Ruf et al., ANNEXIN-V BINDING TO THALASSEMIC ERYTHROCYTES CORRELATES WITH THE EXPRESSION OF PLATELET P-SELECTIN AND REFLECTS A THROMBOPHILIC STATE, Thrombosis and haemostasis, 1997, pp. 1862-1862
IN-VIVO PLATELET ACTIVATION CORRELATES WITH RED-CELL ANIONIC PHOSPHOLIPID EXPOSURE IN PATIENTS WITH BETA-THALASSEMIA MAJOR
Authors: RUF A PICK M DEUTSCH V PATSCHEKE H GOLDFARB A RACHMILEWITZ EA GUILLIN MC ELDOR A
Citation: A. Ruf et al., IN-VIVO PLATELET ACTIVATION CORRELATES WITH RED-CELL ANIONIC PHOSPHOLIPID EXPOSURE IN PATIENTS WITH BETA-THALASSEMIA MAJOR, British Journal of Haematology, 98(1), 1997, pp. 51-56
MOLECULAR FOLLOW-UP OF DISEASE PROGRESSION AND INTERFERON THERAPY IN CHRONIC MYELOCYTIC-LEUKEMIA
Authors: BENYEHUDA D KRICHEVSKY S RACHMILEWITZ EA AVRAHAM A PALUMBO GA FRASSONI F SAHAR D ROSENBAUM H PALTIEL O ZION M BENNERIAH Y
Citation: D. Benyehuda et al., MOLECULAR FOLLOW-UP OF DISEASE PROGRESSION AND INTERFERON THERAPY IN CHRONIC MYELOCYTIC-LEUKEMIA, Blood, 90(12), 1997, pp. 4918-4923
FAMILIAL INCIDENCE OF LYMPHOMA - A POPULATION-BASED STUDY
Authors: PALTIEL O SHMIT T POLLIACK A COHEN A ADLER B HAIM N BENSHACHAR M BARCHANA M EPELBAUM R RACHMILEWITZ EA BENYEHUDA D
Citation: O. Paltiel et al., FAMILIAL INCIDENCE OF LYMPHOMA - A POPULATION-BASED STUDY, Blood, 90(10), 1997, pp. 3934-3934
PROTECTIVE EFFECTS OF TEA POLYPHENOLS AGAINST OXIDATIVE DAMAGE TO RED-BLOOD-CELLS
Authors: GRINBERG LN NEWMARK H KITROSSKY N RAHAMIM E CHEVION M RACHMILEWITZ EA
Citation: Ln. Grinberg et al., PROTECTIVE EFFECTS OF TEA POLYPHENOLS AGAINST OXIDATIVE DAMAGE TO RED-BLOOD-CELLS, Biochemical pharmacology, 54(9), 1997, pp. 973-978
STUDIES ON CURCUMIN AND CURCUMINOIDS .26. ANTIOXIDANT EFFECTS OF CURCUMIN ON THE RED-BLOOD-CELL MEMBRANE
Authors: GRINBERG LN SHALEV O TONNESEN HH RACHMILEWITZ EA
Citation: Ln. Grinberg et al., STUDIES ON CURCUMIN AND CURCUMINOIDS .26. ANTIOXIDANT EFFECTS OF CURCUMIN ON THE RED-BLOOD-CELL MEMBRANE, International journal of pharmaceutics, 132(1-2), 1996, pp. 251-257
MICROSATELLITE INSTABILITY AND P53 MUTATIONS IN THERAPY-RELATED LEUKEMIA SUGGEST MUTATOR PHENOTYPE
Authors: BENYEHUDA D KRICHEVSKY S CASPI O RUND D POLLIACK A ABELIOVICH D ZELIG O YAHALOM V PALTIEL O OR R PERETZ T BENNERIAH S YEHUDA O RACHMILEWITZ EA
Citation: D. Benyehuda et al., MICROSATELLITE INSTABILITY AND P53 MUTATIONS IN THERAPY-RELATED LEUKEMIA SUGGEST MUTATOR PHENOTYPE, Blood, 88(11), 1996, pp. 4296-4303
LONG-TERM ERYTHROPOIETIC RESPONSE TO HYDROXYUREA (28 WEEKS), IN BETA-THALASSEMIA-INTERMEDIA IS UNCHANGED BY ADDING LOW-DOSE ERYTHROPOIETIN (18 WEEKS)
Authors: AKER M RACHMILEWITZ EA
Citation: M. Aker et Ea. Rachmilewitz, LONG-TERM ERYTHROPOIETIC RESPONSE TO HYDROXYUREA (28 WEEKS), IN BETA-THALASSEMIA-INTERMEDIA IS UNCHANGED BY ADDING LOW-DOSE ERYTHROPOIETIN (18 WEEKS), Blood, 88(10), 1996, pp. 2816-2816
HEME ARGINATE THERAPY FOR BETA-THALASSEMIA - IN-VITRO VERSUS IN-VIVO EFFECTS
Authors: RUND D FIBACH E GOLDFARB A FRIEDBERG A RACHMILEWITZ EA
Citation: D. Rund et al., HEME ARGINATE THERAPY FOR BETA-THALASSEMIA - IN-VITRO VERSUS IN-VIVO EFFECTS, Blood, 88(10), 1996, pp. 2831-2831
THE TYRPHOSTIN AG17 INDUCES APOPTOSIS AND INHIBITION OF CDK2 ACTIVITYIN A LYMPHOMA CELL-LINE THAT OVEREXPRESSES BCL2
Authors: PALUMBO GA GAZIT A YAROM N SANDELON Z BANIYASH M RACHMILEWITZ EA LEVITZKI A BENYEHUDA D
Citation: Ga. Palumbo et al., THE TYRPHOSTIN AG17 INDUCES APOPTOSIS AND INHIBITION OF CDK2 ACTIVITYIN A LYMPHOMA CELL-LINE THAT OVEREXPRESSES BCL2, Blood, 88(10), 1996, pp. 3477-3477
MICROSATELLITE INSTABILITY AND P53 MUTATIONS IN THERAPY-RELATED LEUKEMIA SUGGESTS MUTATOR PHENOTYPE
Authors: BENYEHUDA D KRICHEVSKY S CASPI O RUND D POLLIACK A ZELIG O YAHALOM V PALTIEL O OR R RACHMILEWITZ EA
Citation: D. Benyehuda et al., MICROSATELLITE INSTABILITY AND P53 MUTATIONS IN THERAPY-RELATED LEUKEMIA SUGGESTS MUTATOR PHENOTYPE, Blood, 88(10), 1996, pp. 2222-2222
MONITORING DISEASE PROGRESSION AND INTERFERON THERAPY IN CML BY ABL PROMOTER METHYLATION
Authors: BENYEHUDA D KRICHEVSKY S RACHMILEWITZ EA PALUMBO GA FRASSONI F SAAR D BENNERIAH Y
Citation: D. Benyehuda et al., MONITORING DISEASE PROGRESSION AND INTERFERON THERAPY IN CML BY ABL PROMOTER METHYLATION, Blood, 88(10), 1996, pp. 2538-2538
HEMOGLOBIN SWITCHING IN HUMANS IS ACCOMPANIED BY CHANGES IN THE RATIOOF THE TRANSCRIPTION FACTORS, GATA-1 AND SP1
Authors: BACON ER DALYOT N FILON D SCHREIBER L RACHMILEWITZ EA OPPENHEIM A
Citation: Er. Bacon et al., HEMOGLOBIN SWITCHING IN HUMANS IS ACCOMPANIED BY CHANGES IN THE RATIOOF THE TRANSCRIPTION FACTORS, GATA-1 AND SP1, Molecular medicine, 1(3), 1995, pp. 297-305
ACUTE PROMYELOCYTIC LEUKEMIA WITH T(15-17) FOLLOWING TREATMENT OF HODGKINS-DISEASE - A REPORT OF 4 CASES
Authors: GILLIS S SOFER O ZELIG O DANN EJ LOTAN H BENYEHUDA D ISACSON R RACHMILEWITZ EA BENBASSAT I POLLIACK A
Citation: S. Gillis et al., ACUTE PROMYELOCYTIC LEUKEMIA WITH T(15-17) FOLLOWING TREATMENT OF HODGKINS-DISEASE - A REPORT OF 4 CASES, Annals of oncology, 6(8), 1995, pp. 777-779
HYDROXYL RADICAL GENERATION IN BETA-THALASSEMIC RED-BLOOD-CELLS
Authors: GRINBERG LN RACHMILEWITZ EA KITROSSKY N CHEVION M
Citation: Ln. Grinberg et al., HYDROXYL RADICAL GENERATION IN BETA-THALASSEMIC RED-BLOOD-CELLS, Free radical biology & medicine, 18(3), 1995, pp. 611-615
ENHANCED GENERATION OF MONOCYTE TISSUE FACTOR IN PATIENTS WITH POLYCYTHEMIA-VERA
Authors: KORNBERG A YONA R RACHMILEWITZ EA
Citation: A. Kornberg et al., ENHANCED GENERATION OF MONOCYTE TISSUE FACTOR IN PATIENTS WITH POLYCYTHEMIA-VERA, Thrombosis and haemostasis, 73(6), 1995, pp. 1082-1082
NOVEL TREATMENT OPTIONS IN THE SEVERE BETA-GLOBIN DISORDERS
Authors: RODGERS GP RACHMILEWITZ EA
Citation: Gp. Rodgers et Ea. Rachmilewitz, NOVEL TREATMENT OPTIONS IN THE SEVERE BETA-GLOBIN DISORDERS, British Journal of Haematology, 91(2), 1995, pp. 263-268
SUSTAINED INCREASE IN HEMOGLOBIN AND RBC FOLLOWING LONG-TERM ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN TO PATIENTS WITH HOMOZYGOUSBETA-THALASSEMIA
Authors: RACHMILEWITZ EA AKER M PERRY D DOVER G
Citation: Ea. Rachmilewitz et al., SUSTAINED INCREASE IN HEMOGLOBIN AND RBC FOLLOWING LONG-TERM ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN TO PATIENTS WITH HOMOZYGOUSBETA-THALASSEMIA, British Journal of Haematology, 90(2), 1995, pp. 341-345
DEFERIPRONE (L1) CHELATES PATHOLOGICAL IRON DEPOSITS FROM MEMBRANES OF INTACT THALASSEMIC AND SICKLE RED-BLOOD-CELLS BOTH IN-VITRO AND IN-VIVO
Authors: SHALEV O REPKA T GOLDFARB A GRINBERG L ABRAHAMOV A OLIVIERI NF RACHMILEWITZ EA HEBBEL RP
Citation: O. Shalev et al., DEFERIPRONE (L1) CHELATES PATHOLOGICAL IRON DEPOSITS FROM MEMBRANES OF INTACT THALASSEMIC AND SICKLE RED-BLOOD-CELLS BOTH IN-VITRO AND IN-VIVO, Blood, 86(5), 1995, pp. 2008-2013
AN IMPROVED METHOD FOR DIAGNOSIS OF POLYCYTHEMIA-VERA BASED ON FLOW CYTOMETRIC ANALYSIS OF AUTONOMOUS GROWTH OF ERYTHROID PRECURSORS IN LIQUID CULTURE
Authors: MANOR D RACHMILEWITZ EA FIBACH E
Citation: D. Manor et al., AN IMPROVED METHOD FOR DIAGNOSIS OF POLYCYTHEMIA-VERA BASED ON FLOW CYTOMETRIC ANALYSIS OF AUTONOMOUS GROWTH OF ERYTHROID PRECURSORS IN LIQUID CULTURE, Blood, 86(10), 1995, pp. 186-186
MOLECULAR ANALYSIS OF SECONDARY LEUKEMIAS - MUTATOR PHENOTYPE AS THE CAUSE OF DIFFERENT P53 MUTATIONS IN MULTIPLE MALIGNANCIES IN THE SAME INDIVIDUAL
Authors: CASPI O KRICHEVSKY S RUND D ABELIOVICH D ZELIG O POLLIACK A PALTIEL O RACHMILEWITZ EA BENYEHUDA D
Citation: O. Caspi et al., MOLECULAR ANALYSIS OF SECONDARY LEUKEMIAS - MUTATOR PHENOTYPE AS THE CAUSE OF DIFFERENT P53 MUTATIONS IN MULTIPLE MALIGNANCIES IN THE SAME INDIVIDUAL, Blood, 86(10), 1995, pp. 656-656
THE PROCOAGULANT ACTIVITY OF RED-BLOOD-CELLS (RBC) FROM PATIENTS WITHBETA-THALASSEMIA, DETERMINED BY ANNEXIN-V BINDING, CORRELATES WITH IN-VIVO PLATELET ACTIVATION
Authors: ELDOR A PICK M DEUTSCH V GOLDFARB A RACHMILEWITZ EA BEZEAUD A GUILLIN MC RUF A
Citation: A. Eldor et al., THE PROCOAGULANT ACTIVITY OF RED-BLOOD-CELLS (RBC) FROM PATIENTS WITHBETA-THALASSEMIA, DETERMINED BY ANNEXIN-V BINDING, CORRELATES WITH IN-VIVO PLATELET ACTIVATION, Blood, 86(10), 1995, pp. 1920-1920
Risultati: 1-25 | 26-50